813 results on '"Tzioufas, Athanasios G."'
Search Results
2. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
3. Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study
4. Sjögren’s Syndrome
5. FHBF: Federated hybrid boosted forests with dropout rates for supervised learning tasks across highly imbalanced clinical datasets
6. Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study
7. List of contributors
8. The Variable Clinical Presentation of Sjögren’s Syndrome
9. IL‐1β/DNA complex elevation distinguishes autoinflammatory disorders from autoimmune and infectious diseases
10. Dealing with Open Issues and Unmet Needs in Healthcare Through Ontology Matching and Federated Learning
11. Sjogren’s Syndrome (Ss) in Progressive Systemic Sclerosis (SSc)
12. Causes of Exocrine Gland Dysfunction in Sjögren’s
13. Addressing the clinical unmet needs in primary Sjögren’s Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts
14. Helicobacter pylori Eradication Reverses DNA Damage Response Pathway but Not Senescence in Human Gastric Epithelium
15. Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling
16. Utilizing Incremental Learning for the Prediction of Disease Outcomes Across Distributed Clinical Data: A Framework and a Case Study
17. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
18. Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
19. A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data
20. Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
21. Amyloidosis
22. Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways
23. NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease
24. Medical data quality assessment: On the development of an automated framework for medical data curation
25. Sjogren’s Syndrome (Ss) in Progressive Systemic Sclerosis (SSc)
26. Dealing with Open Issues and Unmet Needs in Healthcare Through Ontology Matching and Federated Learning
27. Boosting the performance of MALT lymphoma classification in patients with primary Sjögren’s Syndrome through data augmentation: a case study
28. Common and rare forms of vasculitis associated with Sjögrenʼs syndrome
29. Chapter 13 - Sjögren’s disease
30. Chapter 8 - Precision of diagnostic approaches and individualized therapy toward improving patient outcomes
31. Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
32. Utilisation of primary healthcare services by Sjögren's syndrome patients in the Community of Madrid and associated factors: a population-based cross-sectional study
33. Senescent cells in Giant Cell Arteritis have inflammatory phenotype participating in tissue injury via IL-6 dependent pathways
34. Autoantibodies in Sjögren’s Syndrome and Laboratory Markers
35. Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells
36. Utilizing Incremental Learning for the Prediction of Disease Outcomes Across Distributed Clinical Data: A Framework and a Case Study
37. Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
38. Sjögren’s Syndrome
39. Comparison of pulmonary and small airways function between idiopathic inflammatory myopathies patients with and without interstitial lung disease
40. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis
41. Sjögren’s Syndrome
42. B-Cell Targeted Therapies in Primary Sjögren Syndrome
43. Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease
44. Cryoglobulinaemia
45. The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy
46. Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
47. Predisposing Factors, Clinical Picture, and Outcome of B-Cell Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome
48. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study
49. Primary Sjögren’s syndrome: clinical phenotypes, outcome and the development of biomarkers
50. Current Treatment of Extraglandular Manifestations with Disease-Modifying and Immunosuppressive Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.